logo
Select company
Select metric
$ -56.22MEarning Before Interest & Taxes (EBIT)
VS
Market
15
Sector
33
Industry
46
History
86
$ 0.79Close
$ 0.65 - $ 1.48 52-Week Range
Ticker Information

Ticker

XLO

Company Name

XILIO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XILIO THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XLO - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -56.22M
3/31/2025$ -54.3M
12/31/2024$ -58.24M
9/30/2024$ -62.8M
6/30/2024$ -65.53M
3/31/2024$ -70.96M
12/31/2023$ -76.4M
9/30/2023$ -81.22M
6/30/2023$ -84.26M
3/31/2023$ -89.52M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XILIO THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -55.22M.
  • Over the past 5 years, XILIO THERAPEUTICS INC's average EBIT has been $ -72.4M.
  • The median EBIT for XILIO THERAPEUTICS INC during this period was $ -75.8M
  • XILIO THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ -54.3M.
  • The lowest EBIT recorded by XILIO THERAPEUTICS INC in the same timeframe $ -89.52M

XILIO THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
BRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -69.42MBCAB : BIOATLA INC $ -59.52MGBIO : GENERATION BIO CO $ -72.42MCRIS : CURIS INC $ -38.92MEQ : EQUILLIUM INC $ -19.83MVVOS : VIVOS THERAPEUTICS INC $ -14.32MVRCA : VERRICA PHARMACEUTICALS INC $ -39.54MVERU : VERU INC $ -32.09MIRD : OPUS GENETICS INC $ -58.27MNEPH : NEPHROS INC $ 1.35M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

XLO - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -89.52M

Minimum

Mar 31, 2023

$ -54.3M

Maximum

Mar 31, 2025

$ -72.4M

Average

$ -75.8M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.48M with a standard deviation of $ 130.48M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442M
average$ 28.48M
median$ 847.86K
std$ 130.48M